Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study.
暂无分享，去创建一个
H. Dombret | M. Bernard | P. Chevallier | M. Mohty | M. Béné | N. Ifrah | J. Delaunay | N. Robillard | J. Bladé | P. Talmant | E. Raffoux | C. Fohrer | S. Carras | S. Maury | A. Charbonnier | A. Etienne | T. Guillaume | C. Chabrot